article thumbnail

Study Finds Underestimated Rates of Atopic Dermatitis for Adults 60 and Over

Drug Topics

From 1990 to 2021, researchers explored the global burden of atopic dermatitis among older adults.

459
459
article thumbnail

FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion

Drug Topics

The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.

FDA 503
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

For the First Time Medicaid Net Drug Spending Hits Double-Digits

Drug Topics

Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.

503
503
article thumbnail

Second Interchangeable Biosimilar for Insulin Glargine Approved by FDA

Drug Topics

Insulin glargine-aglr received initial FDA approval in December 2021.

FDA 464
article thumbnail

FDA Approves Tezepelumab for Self-Administration With New Pre-Filled Pen

Drug Topics

After being FDA approved in 2021, tezepelumab (Tezspire) has been approved again for self-administration.

FDA 464
article thumbnail

Health Care Spending Has Shot Back Up to Pre-Pandemic Levels

Drug Topics

The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.

Insurance 452
article thumbnail

STAT+: Bubble bursts: 2021 health tech IPOs and SPACs lose value, burn cash

STAT

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt.

136
136